<DOC>
	<DOCNO>NCT03054155</DOCNO>
	<brief_summary>Patients bilateral hidradenitis axilla , groin and/or inframammary treat one side Alexandrite hair removal laser . The side serve control .</brief_summary>
	<brief_title>Treatment Hidradenitis Suppurativa With Eth 755nm Alexandrite Laser</brief_title>
	<detailed_description>Patients bilateral disease choose participate study . Patients advise discontinue prior systemic HS treatment two week first laser session wash period . One side patient choose treatment side , intrinsic control . Each participant total 4 treatment laser , one treatment per month duration 4 month . Patients participate follow-up clinic visit two month completion last treatment . In laser session , participant allow use benzoyl peroxide 10 % wash skin cleanser clindamycin 1 % solution lotion topical therapy , twice daily treatment control area . At visit , photograph take lesion monitor progression serve comparison control side . The treatment side treat laser adjust accord skin type follow : Skin type I-II ( Fair Caucasian ) : Fluence : 30J/cm2 Skin type III ( Darker Caucasian , light Asian ) : Fluence : 25 J/cm2 Skin type IV ( Mediterranean , Asian , Latin ) : Fluence : 18 J/cm2 Skin type V ( Light skin black , Darker mediterranean ) : Fluence : 16J/cm2 Skin type VI ( Dark skin black ) : Fluence 14 J/cm2 A spot size 12 mm cryogen spray delay 50/50 use treated patient . The treatment area exceed 15cm x 15cm . If patient tolerate treatment Alexandrite laser , patient terminate study . Following treatment session , patient give ice pack reduce discomfort patient may experience result treatment laser . Clinical evaluation photograph determine improvement .</detailed_description>
	<mesh_term>Hidradenitis</mesh_term>
	<mesh_term>Hidradenitis Suppurativa</mesh_term>
	<criteria>Age 1865 Patients Hidradenitis Suppurativa bilateral symmetric disease one anatomic sit involvement . Pregnant patient patient plan get pregnant time study Patients systemic treatment Hidradenitis Suppurativa Patients photosensitivity disorder Patients unable tolerate laser treatment Intake photosensitive medication</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>hidradenitis suppurativa</keyword>
	<keyword>hidradenitis</keyword>
	<keyword>laser</keyword>
</DOC>